Drugs / LUCAR-E9D
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT07093411 | Aug 2025 → Aug 2028 expected | B-cell non-Hodgkin lymphoma | Beijing GoBroad Hospital | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LUCAR-E9D | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07093411 ↗ |
| Modality | Cell therapy | “LUCAR-E9D or LUCAR-E9K cells product” NCT07093411 ↗ |
| Route | Other | “LUCAR-E9D or LUCAR-E9K cells infusion” NCT07093411 ↗ |